Amount Raised
$350 Million
Round Type
Post-IPO Equity
WalthamBiotechnologyHealth CareTherapeuticsInvestors
Description
On December 9, 2025, Dyne Therapeutics, Inc entered into an underwriting agreement for an underwritten public offering of shares. The offering includes 18,980,478 shares of common stock at a public offering price of $18.44 per share. The funds will support Dyne's strategy to develop therapies for various diseases. This move is part of the company's ongoing commitment to innovation in biotechnology.
Quick answer
Dyne Therapeutics raised $350 Million in a Post-IPO Equity round, dated December 10, 2025. Investors: Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated, Jefferies LLC and Morgan Stanley & Co. LLC. Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Dyne Therapeutics raise?
- Dyne Therapeutics raised $350 Million in a Post-IPO Equity round on December 10, 2025.
- Who invested in Dyne Therapeutics?
- Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated, Jefferies LLC and Morgan Stanley & Co. LLC are named as investors in this round.
- What does Dyne Therapeutics do?
- Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
- Where is Dyne Therapeutics based and how big is it?
- Dyne Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 270 employees.
- Who are the decision-makers at Dyne Therapeutics?
- Fundz holds 2 contacts at Dyne Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Dyne Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
- ImmunoMet Therapeutics raised $842K on January 21, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
- Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
- Aurora Therapeutics raised $16M (Seed) on January 9, 2026.
Who to call at Dyne Therapeutics, and when
A new round usually means Dyne Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dyne Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dyne Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dyne Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dyne Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dyne Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.